iBio, Inc. - Common Stock (IBIO)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock
Total 13F shares
43,383,633
Share change
-1,127,661
Total reported value
$65,497,510
Put/Call ratio
194%
Price per share
$1.51
Number of holders
81
Value change
-$1,744,149
Number of buys
30
Number of sells
51

Institutional Holders of iBio, Inc. - Common Stock (IBIO) as of Q2 2021

As of 30 Jun 2021, iBio, Inc. - Common Stock (IBIO) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,383,633 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Nuveen Asset Management, LLC, Bank of New York Mellon Corp, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and Squarepoint Ops LLC. This page lists 81 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.